We are a medical technology company that develops, manufactures, and markets non-invasive cerebral and tissue oximeters used in patient monitoring that are consistent with our Vision:
Company profile
Ticker
CASM
Exchange
Website
CEO
Thomas M. Patton
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
61123096
Latest filings (excl ownership)
15-12G
Securities registration termination
29 Apr 19
EFFECT
Notice of effectiveness
29 Apr 19
EFFECT
Notice of effectiveness
29 Apr 19
EFFECT
Notice of effectiveness
29 Apr 19
EFFECT
Notice of effectiveness
29 Apr 19
EFFECT
Notice of effectiveness
29 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Apr 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Apr 19
Latest ownership filings
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|